Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative Analysis of Instrumental Variables on the Assignment of Buprenorphine/Naloxone or Methadone for the Treatment of Opioid Use Disorder.
Homayra F, Enns B, Min JE, Kurz M, Bach P, Bruneau J, Greenland S, Gustafson P, Karim ME, Korthuis PT, Loughin T, MacLure M, McCandless L, Platt RW, Schnepel K, Shigeoka H, Siebert U, Socias E, Wood E, Nosyk B. Homayra F, et al. Among authors: loughin t. Epidemiology. 2024 Mar 1;35(2):218-231. doi: 10.1097/EDE.0000000000001697. Epub 2023 Jan 30. Epidemiology. 2024. PMID: 38290142
Comparative effectiveness of urine drug screening strategies alongside opioid agonist treatment in British Columbia, Canada: a population-based observational study protocol.
Guerra-Alejos BC, Kurz M, Min JE, Dale LM, Piske M, Bach P, Bruneau J, Gustafson P, Hu XJ, Kampman K, Korthuis PT, Loughin T, Maclure M, Platt RW, Siebert U, Socías ME, Wood E, Nosyk B. Guerra-Alejos BC, et al. Among authors: loughin t. BMJ Open. 2023 May 31;13(5):e068729. doi: 10.1136/bmjopen-2022-068729. BMJ Open. 2023. PMID: 37258082 Free PMC article.
What is the ideal time to begin tapering opioid agonist treatment? A protocol for a retrospective population-based comparative effectiveness study in British Columbia, Canada.
Yan R, Kurz M, Guerra-Alejos BC, Min JE, Bach P, Greenland S, Gustafson P, Karim E, Korthuis PT, Loughin T, McCandless L, Platt RW, Schnepel K, Seaman S, Socías ME, Wood E, Xie H, Nosyk B. Yan R, et al. Among authors: loughin t. BMJ Open. 2024 Apr 29;14(4):e083453. doi: 10.1136/bmjopen-2023-083453. BMJ Open. 2024. PMID: 38684262 Free PMC article.
Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder.
Nosyk B, Min JE, Homayra F, Kurz M, Guerra-Alejos BC, Yan R, Piske M, Seaman SR, Bach P, Greenland S, Karim ME, Siebert U, Bruneau J, Gustafson P, Kampman K, Korthuis PT, Loughin T, McCandless LC, Platt RW, Schnepel KT, Socías ME. Nosyk B, et al. Among authors: loughin t. JAMA. 2024 Dec 3;332(21):1822-1831. doi: 10.1001/jama.2024.16954. JAMA. 2024. PMID: 39418046
Development and validation of the Kids Disability Screen for children with juvenile idiopathic arthritis: results from the CAPRI Registry.
Houghton K, McPherson M, Surjanovic N, Loughin T, Berard R, Proulx-Gauthier JP, Chédeville G, Rumsey D, Schmeling H, Luca N, Johnson N, Gerschman T, Miettunen P, Tam H, Lim L, Morishita K, Scuccimarri R, Roth J, Duffy C, Tucker L, Feldman BM, Guzman J; CAPRI Registry Investigators. Houghton K, et al. Among authors: loughin t. Rheumatology (Oxford). 2022 Nov 28;61(12):4835-4844. doi: 10.1093/rheumatology/keac146. Rheumatology (Oxford). 2022. PMID: 35438140
Causal pathways to health-related quality of life in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort.
Oen K, Tian J, Loughin TM, Shiff NJ, Tucker LB, Huber AM, Berard RA, Levy DM, Rumsey DG, Tse SM, Chan M, Feldman BM, Duffy CM, Guzman J; ReACCh-Out Investigators. Oen K, et al. Among authors: loughin tm. Rheumatology (Oxford). 2021 Oct 2;60(10):4691-4702. doi: 10.1093/rheumatology/keab079. Rheumatology (Oxford). 2021. PMID: 33506861
46 results